Medical technology company Heartflow said on Friday it was targeting a valuation of up to $1.32 billion in its U.S. initial ...

A top U.S. cardiologist says doctors are "underdosing" high-potency statins to patients who have high levels of "bad" ...

Heartflow's quarterly loss widened over the year-ago period, the healthcare company disclosed in its paperwork for a U.S. initial public offering on Thursday, at a time when it looks to tap into ...

“It’s one thing to be alive, it’s another to be alive and well.” Cardiovascular risks on the rise The study analyzed government data on deaths from heart disease between 1970 and 2022.

A multidisciplinary prehabilitation protocol shows promise in reversing frailty and improving outcomes for patients with ...

Deaths from heart failure increased 146% over the same time period, while death due to persistent high blood pressure rose by 106%. Changes in cardiovascular risk factors are contributing to the ...